Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialFrancesca Poggio, Lucia Del Mastro, Simone Nardin et al.|ESMO Open|2024Cited by 5
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER)Carmine De Angelis, Grazia Arpino, Martina Pagliuca et al.|The Oncologist|2025Cited by 0